{"id":"W2343851725","doi":"10.1093/annonc/mdv337.07","title":"Effect of nivolumab (NIVO) on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): results of a phase III study (CheckMate 066)","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Nivolumab; Quality of life (healthcare); Internal medicine; Dacarbazine; Oncology; Temozolomide; Visual analogue scale; Randomized controlled trial; Cancer; Chemotherapy; Surgery; Immunotherapy; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006619375,0.0004721264,0.0008319959,0.0001338609,0.0002237195,0.0004754075,0.0003586472,0.0004197517,0.001042316],"category_scores_gemma":[0.0007710052,0.0001744202,0.001066872,0.0001913375,0.0002959339,0.0003785283,0.0002032391,0.001309226,0.0001655853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004220496,"about_ca_system_score_gemma":0.0004133855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001242497,"about_ca_topic_score_gemma":0.002926064,"domain_scores_codex":[0.9998044,0.0001048072,0.00001114418,0.00002805822,0.00001814587,0.00003337374],"domain_scores_gemma":[0.9996302,0.0001160794,0.00007599412,0.00002058565,0.00001781482,0.0001393081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6074683,0.03337723,0.09312478,0.001012964,0.003368277,0.0001857749,0.0003010906,0.003035848,0.02674533,0.0001427117,0.0032284,0.2280092],"study_design_scores_gemma":[0.2115223,0.3960935,0.3810127,0.0001144149,0.002205546,0.0003312634,0.0002232049,0.002616505,0.003508701,0.0001994867,0.002115378,0.00005697944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980431,0.001022731,0.00004278898,0.0001005119,0.00002797248,0.00007358952,0.0002308115,0.00001165151,0.0004468788],"genre_scores_gemma":[0.9979355,0.0006757583,0.0002535372,0.0002066045,0.00003967544,0.00009330699,0.0004255046,0.000005119752,0.0003650224],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001242497,"threshold_uncertainty_score":0.0035007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07227636460268878,"score_gpt":0.4092405092119963,"score_spread":0.3369641446093075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}